Administrative layoffs at Connecticut's largest private employer signal stresses on academic medical centers facing federal ...

Most cells in the human body each contain about six feet of DNA. Yet the nucleus, where DNA is coiled, is no larger than a ...

CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...

The American Association for the Advancement of Science recognized Yale researchers for their contributions to medicine, ...

Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with ...

Allison Aviles, of New Britain, has suffered back-to-back ankle injuries. Last fall, she had surgery after tearing a tendon ...

Craig Roy is the Waldemar Von Zedtwitz Professor of Microbial Pathogenesis and of Immunobiology at Yale School of Medicine (YSM) and director of the Yale Combined Program in the Biological and ...

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...

Richard Lifton, president of The Rockefeller University and an eminent life scientist and educator, will join the Corporation as of July 1, 2025.

A new study led by scientists at Yale School of Medicine and New York University (NYU) Grossman School of Medicine unveils a previously unknown protective mechanism employed by the gene — and how an ...

Scientists have re-created a pain pathway in the brain by growing four key clusters of human nerve cells in a dish. This ...